Long-Term Follow up of a Randomized Phase 2 Study of Low-Dose Decitabine Versus Low-Dose Azacitidine in Lower-Risk Myelodysplastic Syndromes, Guillermo Montalban-Bravo, Elias Jabbour, Caleb Class, Nicholas Short, Rashmi Kanagal-Shamanna, Tapan Kadia, Gautam Borthakur, Naveen Pemmaraju, Koji Sasaki, Zeev Estrov, Jorge Cortes, Farhad Ravandi, Yesid Alvarado, Rami Komrokji, Mikkael Sekeres, David Steensma, Amy DeZern, Gail Roboz, Hui Yang, Hagop Kantarjian, Guillermo Garcia-Manero
Scholarship and Professional Work – COPHS

Genomic Context and TP53 Allele Frequency Define Prognostic Subgroups and Response Outcomes in TP53 Mutated Myelodysplastic Syndromes, Guillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Christopher Benton, Caleb Class, Kelly Chien, Koji Sasaki, Kiran Naqvi, Yesid Alvarado, Tapan Kadia, Farhad Ravandi, Jorge Cortes, Naval Daver, Koichi Takahashi, Courtney DiNardo, Elias Jabbour, Gautam Borthakur, Naveen Pemmaraju, Marina Konopleva, Sherry Pierce, Carlos Bueso-Ramos, Michael Andreeff, Keyur Patel, Hagop Kantarjian, Guillermo Garcia-Manero
Scholarship and Professional Work – COPHS